Takao Tsunematsu

Title: Takao Tsunematsu: Innovator in Pharmaceutical Composition

Introduction

Takao Tsunematsu is a notable inventor based in Shiraoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on dihydropyridine compounds. His research has led to advancements in drug formulations that enhance bioavailability and absorption.

Latest Patents

Tsunematsu holds a patent for a pharmaceutical composition that includes a 1:1 solvate of a specific dihydropyridine compound. This composition, which is designed to be easily prepared into various forms such as tablets, capsules, granules, and powders, exhibits enhanced bioavailability. It provides a high blood concentration of the active component NZ-105, ensuring a high total drug absorption.

Career Highlights

Throughout his career, Takao Tsunematsu has worked with reputable companies, including Zeria Pharmaceutical Co., Ltd. and Nissan Chemical Industries Limited. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Tsunematsu has collaborated with notable coworkers such as Masaharu Miyajima and Yukiya Yamaguchi. Their joint efforts have furthered research and development in the pharmaceutical sector.

Conclusion

Takao Tsunematsu's contributions to pharmaceutical compositions highlight his role as an innovator in the field. His work continues to impact drug formulation and bioavailability, showcasing the importance of research and development in pharmaceuticals.